Cytogenetics and gene mutations influence survival in older patients with acute myeloid leukemia treated with azacitidine or conventional care-Reference-Cited by-同舟云学术

Cytogenetics and gene mutations influence survival in older patients with acute myeloid leukemia treated with azacitidine or conventional care

Published:2018-10-01 Issue:12 Volume:32 Page:2546-2557
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Döhner Hartmut,Dolnik Anna,Tang Lin,Seymour John F.,Minden Mark D.,Stone Richard M.,del Castillo Teresa Bernal,Al-Ali Haifa Kathrin,Santini Valeria,Vyas Paresh^ORCID,Beach C. L.,MacBeth Kyle J.,Skikne Barry S.,Songer Steve,Tu Nora,Bullinger Lars,Dombret Hervé

Funder

This study was funded by Celgene Corporation.

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/s41375-018-0257-z.pdf

Reference42 articles.

1. Dohner H, Estey EH, Amadori S, Appelbaum FR, Buchner T, Burnett AK, et al. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. Blood. 2010;115:453–74.

2. Bullinger L, Dohner K, Dohner H. Genomics in acute myeloid leukemia diagnosis and pathways. J Clin Oncol. 2017;35:1–13.

3. Papaemmanuil E, Gerstung M, Bullinger L, Gaidzik VI, Paschka P, Roberts ND, et al. Genomic classification and prognosis in acute myeloid leukemia. N Engl J Med. 2016;374:2209–21.